Results 121 to 130 of about 3,113,169 (328)
Metabolic Consequences of Rheumatoid Arthritis
Arthritis Care &Research, EarlyView.Patients with rheumatoid arthritis (RA) may have metabolic disruption, which can contribute to adverse long‐term outcomes, for multiple reasons. Patients with RA appear to have a higher risk of sarcopenia, type 1 and type 2 diabetes mellitus, metabolic syndrome, and hypertension. Systemic inflammation in RA can cause a “lipid paradox,” with reduced low‐
Stevie Barry +2 more
wiley +1 more source
Ranking the ‘Diamond Core’ economic journals: A note [PDF]
By estimating the production frontier with the application of Data Envelopment Analysis (DEA) we rank the ‘Diamond Core’ economic journals as has been presented by Diamond (1989).
Halkos, George, Tzeremes, Nickolaos
core +1 more source
Arthritis Care &Research, EarlyView.Objective We aimed to assess whether high‐sensitivity C‐reactive protein (hsCRP) levels could predict the development of psoriatic arthritis (PsA) in patients with psoriasis. Methods We analyzed data from a prospective cohort of patients with psoriasis without PsA at enrollment.
Lihi Eder +5 more
wiley +1 more source
Arthritis Care &Research, EarlyView.Objective We estimated incidence rates of avoidable hospitalizations by persons with rheumatoid arthritis (RA) relative to the general population. Methods We identified individuals meeting a validated case definition for RA based on International Classification of Diseases, Ninth Revision, Clinical Modification (ICD‐9‐CM) and ICD‐10‐CA codes in years ...
Dani G. Contreras +6 more
wiley +1 more source
An Index to the Biographical Notices, papers on the History of Medicine, and Reviews of Books on that subject, which have appeared in the Irish Journal of Medical Science from September, 1916 to December, 1954 [PDF]
, 1955 J. D. H. Widdess
openalex +1 more source
Arthritis Care &Research, EarlyView.Objective The objective of this study was to evaluate and compare the risk of hepatotoxicity associated with the use of febuxostat and benzbromarone in patients with gout. Methods New users of febuxostat or benzbromarone with monitoring of liver function at least three times in a year after initiation of the study drugs were identified from an ...
Wenyan Sun +8 more
wiley +1 more source